12 of 306 unique stocks in common · Jaccard: 3.9%
A weighted portfolio overlap of 4.63% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹4.63 is allocated to the exact same companies at the same relative proportions. The schemes share 12 common holdings.
The largest overlapping asset in their portfolios is Aster DM Healthcare, which commands a weight of 0.64% in HDFC Flexi Cap Fund and 0.74% in IB20-Groww Nifty Smallcap 250 Index Fund. Holding both schemes increases your concentration in Aster DM Healthcare rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in HDFC | in IB20-Groww |
|---|---|---|
| Aster DM HealthcareHealthcare Services | 0.64% | 0.74% |
| Piramal PharmaPharmaceuticals & Biotechnology | 1.53% | 0.59% |
| Kalpataru Projects InternationalConstruction | 0.59% | 0.68% |
| Dr. Lal Path LabsHealthcare Services | 0.66% | 0.58% |
| CyientIT - Services | 0.49% | 0.47% |
| Crompton Greaves Consumer ElectricalsConsumer Durables | 0.40% | 0.87% |
| The Ramco CementsCement & Cement Products | 0.34% | 0.63% |
| Sapphire Foods IndiaLeisure Services | 0.36% | 0.32% |
| Metropolis HealthcareHealthcare Services | 0.35% | 0.25% |
| Nuvoco Vistas CorporationCement & Cement Products | 0.60% | 0.20% |
| BirlasoftIT - Software | 0.13% | 0.29% |
| Neuland LaboratoriesPharmaceuticals & Biotechnology | 0.12% | 0.68% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.